(Q33369478)

26 July 2017

title

Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial (English)

1 reference

26 July 2017

1 reference

1 reference

Lucia Del Mastro

2

0 references

Paolo Pronzato

object named as

Paolo Pronzato

9

0 references

Paolo Bruzzi

object named as

Paolo Bruzzi

14

0 references

Editta Baldini

4

object named as

Editta Baldini

1 reference

26 July 2017

13

Riccardo Rosso

1 reference

26 July 2017

Marco Venturini

1

1 reference

26 July 2017

Enrico Aitini

3

1 reference

26 July 2017

Cinzia Caroti

5

1 reference

26 July 2017

Antonio Contu

6

1 reference

26 July 2017

Franco Testore

7

1 reference

26 July 2017

Fulvio Brema

8

1 reference

26 July 2017

Giovanna Cavazzini

10

1 reference

26 July 2017

Mario Roberto Sertoli

11

1 reference

26 July 2017

Giuseppe Canavese

12

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

Journal of the National Cancer Institute

26 July 2017

published in

1 reference

26 July 2017

volume

97

1 reference

26 July 2017

issue

23

1 reference

26 July 2017

page(s)

1724-1733

1 reference

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI398

Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French Adjuvant Study Group 05 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI398

Predicting the course of Gompertzian growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI398

Theoretical concepts and the emerging role of taxanes in adjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI398

Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI398

Erythropoietin and granulocyte-macrophage colony-stimulating factor allow acceleration and dose escalation of cyclophosphamide/epidoxorubicin/5-fluorouracil chemotherapy: a dose-finding study in patients with advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI398

Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: results of a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella I

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI398

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI398

HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI398

Risk for the development of treatment-related acute myelocytic leukemia and myelodysplastic syndrome among patients with breast cancer: review of the literature and the National Surgical Adjuvant Breast and Bowel Project experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI398

Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline-based neoadjuvant chemotherapy in patients with breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI398

Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI398

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI398

Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI398

A pilot study of accelerated cyclophosphamide, epirubicin and 5-fluorouracil plus granulocyte colony stimulating factor as adjuvant therapy in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI398

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJI398

1 reference

26 July 2017

1 reference